首页|期刊导航|Pharmacoeconomics and Policy|Disease burden of pulmonary arterial hypertension attributable to three factors based on the Global Burden of Disease 2021

Disease burden of pulmonary arterial hypertension attributable to three factors based on the Global Burden of Disease 2021

Hanxiang Chen Yaqun Wang Fanyu Dong Zixuan Lv Shengnan Duan Anqi Wang Ni Yuan

Pharmacoeconomics and Policy2026，Vol.2Issue(2)：P.77-85,9.

Pharmacoeconomics and Policy2026，Vol.2Issue(2)：P.77-85,9.DOI:10.1016/j.pharp.2026.06.002

Disease burden of pulmonary arterial hypertension attributable to three factors based on the Global Burden of Disease 2021

Hanxiang Chen ¹Yaqun Wang ²Fanyu Dong ¹Zixuan Lv ²Shengnan Duan ¹Anqi Wang ¹Ni Yuan¹

作者信息

1. School of Public Health,Dalian Medical University,Dalian,Liaoning,116000,China Innovative Drug Policy and Medical Insurance Research Center,Dalian Medical University,Dalian,Liaoning,116000,China
2. School of Public Health,Dalian Medical University,Dalian,Liaoning,116000,China Innovative Drug Policy and Medical Insurance Research Center,Dalian Medical University,Dalian,Liaoning,116000,China Dong Fureng Institute of Economic and Social Development,Wuhan University,Wuhan,430072,China
折叠

摘要

关键词

Pulmonary/arterial/hypertension/Global/Burden/of/Disease/2021/Global/burden/Prevalence/Mortality/Disability-adjusted/life-years

分类

医药卫生

引用本文复制引用

Hanxiang Chen,Yaqun Wang,Fanyu Dong,Zixuan Lv,Shengnan Duan,Anqi Wang,Ni Yuan..Disease burden of pulmonary arterial hypertension attributable to three factors based on the Global Burden of Disease 2021[J].Pharmacoeconomics and Policy,2026,2(2):P.77-85,9.

基金项目

supported by the 2022 Basic Research Project of the Educational Department of Liaoning Province,China(Grant No.:LJKMR20221296)。（Grant No.:LJKMR20221296）

Pharmacoeconomics and Policy

ISSN：2950-2667

访问量0

下载量0

段落导航